Department of Medicine, Duke University Health System, Durham, North Carolina.
Health Services Research and Development Center of Innovation, Durham VA Health Care System, Durham, North Carolina.
JAMA Health Forum. 2021 Nov 5;2(11):e213626. doi: 10.1001/jamahealthforum.2021.3626. eCollection 2021 Nov.
The dialysis industry is highly concentrated, with large dialysis organizations now providing dialysis for more than 85% of patients with kidney failure in the United States. In 2011, Medicare introduced a new Prospective Payment System (PPS) for end-stage kidney disease, which bundled payment for dialysis care into 1 payment per patient. Trends in dialysis facility consolidation after the PPS went into effect are unknown.
To determine whether the introduction of the PPS in 2011 was associated with an acceleration in acquisitions and closures of small dialysis chains (<20 facilities) and independently owned facilities.
This retrospective cohort study included all Medicare-certified independent or small chain-affiliated dialysis facilities in the continental US between 2006 and 2016. Data were obtained from Medicare and the US Renal Data System and were analyzed in 2020.
The PPS.
Discrete time hazard models were used to estimate the odds of acquisition and closure before the PPS (2006-2010) vs after the PPS (2011-2016). Analyses controlled for facility, market, and regional demographic characteristics. The average predicted marginal probabilities of acquisition and closure over time were estimated.
The proportion of small chain-affiliated and independently owned facilities declined from 29% (1383 of 4750 facilities) in 2006 to 15% (1038 of 6738) in 2016. Among 13 481 facility-years, 6352 (47%) were for profit, and mean (SD) census was 68 (59) patients. Overall, 3286 (24%) facilities opened during the observation period. The proportion of acquisitions that occurred each year varied from 1.1% (12 of 1065 facilities in 2015) to 7.2% (86 of 1192 facilities in 2012), while closures varied from 0.8% (9 of 1065 facilities in 2015) to 2.2% (28 of 1286 facilities in 2010), making both fairly rare. There was a 3.48 higher odds of acquisition in the post-PPS period compared with the pre-PPS period (95% CI, 1.62-7.47; = .001). The odds of closure before and after the PPS were not statistically significantly different (odds ratio, 2.03; 95% CI, 0.61-6.73; = .25). Facilities that opened during the observation period had a 7.2% higher predicted probability of acquisition compared with older facilities (95% CI, 5.4%-9.0%; < .001).
In this cohort study of continental US Medicare-certified dialysis facilities, small-chain and independently owned facilities retained a declining share of the dialysis market. Further research should evaluate the effect of continued dialysis market consolidation on patient access, health care utilization, and clinical outcomes.
透析行业高度集中,现在大型透析机构为美国超过 85%的肾衰竭患者提供透析服务。2011 年,医疗保险推出了一种新的终末期肾病前瞻性支付系统(PPS),将透析护理的支付捆绑到每位患者的 1 次支付中。在 PPS 生效后,透析机构整合的趋势尚不清楚。
确定 2011 年 PPS 的引入是否与小型透析连锁店(<20 家)和独立拥有的设施的加速收购和关闭有关。
设计、地点和参与者:本回顾性队列研究包括 2006 年至 2016 年间美国大陆所有经医疗保险认证的独立或小型连锁附属透析机构。数据来自医疗保险和美国肾脏数据系统,并于 2020 年进行分析。
PPS。
使用离散时间风险模型来估计 PPS 之前(2006-2010 年)和之后(2011-2016 年)收购和关闭的可能性。分析控制了设施、市场和区域人口统计学特征。估计了随时间推移收购和关闭的平均预测边缘概率。
2006 年,小连锁附属和独立拥有的设施比例为 29%(4750 家设施中的 1383 家),到 2016 年降至 15%(6738 家设施中的 1038 家)。在 13481 个设施年中,6352 个(47%)为营利性,平均(SD)患者数为 68(59)。总体而言,在观察期间有 3286 个(24%)设施开业。每年发生收购的比例从 2015 年的 1.1%(1065 家设施中的 12 家)到 2012 年的 7.2%(1192 家设施中的 86 家)不等,而关闭比例从 2015 年的 0.8%(1065 家设施中的 9 家)到 2010 年的 2.2%(1286 家设施中的 28 家)不等,两者都相当罕见。与 PPS 前时期相比,PPS 后时期收购的可能性高出 3.48 倍(95%CI,1.62-7.47; = .001)。PPS 前后关闭的可能性没有统计学显著差异(比值比,2.03;95%CI,0.61-6.73; = .25)。在观察期间开业的设施与较老的设施相比,收购的预测概率高 7.2%(95%CI,5.4%-9.0%; < .001)。
在这项对美国大陆医疗保险认证的透析设施的队列研究中,小连锁和独立拥有的设施在透析市场的份额持续下降。进一步的研究应该评估持续的透析市场整合对患者获得、医疗保健利用和临床结果的影响。